TP53 and B-cell chronic lymphocytic leukemia: Regarding the effect of del17p in primary cancer cells, gene expression profiling revealed under-expression of p53 in CLL cells with a 17p deletion [41], but here it is important to note that p53 mRNA expression may be reduced by mechanisms other than TP53 LOH [17, 33].